General information
  • Disease category Injury , Surgery (BASEC)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Basel, Chur, Zurich
    (BASEC)
  • Contact Marcel Aeschlimann clinicaltrials@41medical.com (BASEC)
  • Data Source(s) BASEC: Import from 15.04.2025 ICTRP: N/A
  • Last update 15.04.2025 08:30
HumRes63664 | SNCTP000005778 | BASEC2023-D0103

“Safety and performance of the biphasic plate for the distal femur: A multicenter case series”

  • Disease category Injury , Surgery (BASEC)
  • Recruitment status recruitment ongoing (BASEC/ICTRP)
  • Trial sites
    Basel, Chur, Zurich
    (BASEC)
  • Contact Marcel Aeschlimann clinicaltrials@41medical.com (BASEC)
  • Data Source(s) BASEC: Import from 15.04.2025 ICTRP: N/A
  • Last update 15.04.2025 08:30

Summary description of the study

The treatment of distal femur fractures can be challenging and may involve many complications. For this reason, the sponsor of this study has developed a new type of implant, the biphasic plate DF, for the fixation of the fracture. This new device is designed to reduce complications and allow the patient to load the fracture earlier. The aim of this study is to collect data on the use of the biphasic plate DF regarding the safety of application and the performance of the implant. Your participation in this study will last for one year or until clinical healing of the fracture - whichever occurs first. You will be treated according to local treatment standards. Data on standard treatment will be collected in the study. The only collected data that may not be part of standard treatment consists of a questionnaire in which you will be asked about your quality of life and your pain on a scale from 0 to 10.

(BASEC)

Intervention under investigation

The biphasic plate DF, for fixation of a femur fracture.

(BASEC)

Disease under investigation

You have either undergone implantation of a biphasic plate DF due to a femur fracture, or such surgery is planned.

(BASEC)

Criteria for participation in trial
- Patients aged over 18 years - Patients with distal femur fractures requiring internal fixation and treated with the biphasic plate DF. - Patients who are willing and able to comply with postoperative follow-up visits according to local treatment standards. (BASEC)

Exclusion criteria
- The patient is participating in another clinical intervention study. - Need for application of an additional (medial/ventral) plate (double plating) or an intramedullary nail. (BASEC)

Trial sites

Basel, Chur, Zurich

(BASEC)

not available

Sponsor

41medical AG

(BASEC)

Contact

Contact Person Switzerland

Marcel Aeschlimann

+41 32 645 41 41

clinicaltrials@41medical.com

41medical AG

(BASEC)

Scientific Information

not available

Name of the authorising ethics committee (for multicentre studies, only the lead committee)

Ethics Committee Zurich

(BASEC)

Date of authorisation

23.01.2024

(BASEC)


ICTRP Trial ID
not available

Official title (approved by ethics committee)
Safety and performance of the Biphasic Plate Distal Femur: A multicenter case series (BASEC)

Academic title
not available

Public title
not available

Disease under investigation
not available

Intervention under investigation
not available

Type of trial
not available

Trial design
not available

Inclusion/Exclusion criteria
not available

not available

Primary and secondary end points
not available

not available

Registration date
not available

Incorporation of the first participant
not available

Secondary sponsors
not available

Additional contacts
not available

Secondary trial IDs
not available

Results-Individual Participant Data (IPD)
not available

Further information on the trial
not available

Results of the trial

Results summary

not available

Link to the results in the primary register

not available